Results 31 to 40 of about 25,062 (184)
Overview of antifungal dosing in invasive candidiasis [PDF]
, 2018 In the past, most antifungal therapy dosing recommendations for invasive candidiasis followed a 'one-size fits all' approach with recommendations for lowering maintenance dosages for some antifungals in the setting of renal or hepatic impairment.
Lewis RE, Pea F
core +3 more sources
Jurnal Penyakit Dalam Indonesia, 2017 Introduction. Mortality rate of invasive candidiasis is still high, approximately 30-70%. Every study has a variety mortality rate depend on study design and sample. There is no data in Indonesia about profile and mortality factors analysis in critically
Ardi Ardian +4 more
doaj +1 more source
Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study [PDF]
, 2013 Background: Candida spp. are a frequent cause of nosocomial bloodstream infections worldwide. Objective: To evaluate the use patterns and outcomes associated with intravenous (IV) fluconazole therapy in intensive care units in Spain and Germany ...
Wissing, Heimo +7 more
core +1 more source
Invasive candidiasis in a Brazilian neonatal intensive care unit
Revista Brasileira de Saúde Materno Infantil, 2021 Objectives: to describe the epidemiology of invasive candidiasis in a neonatal intensive care unit. Methods: cross-sectional study that included all neonates with invasive candidiasis confirmed by blood culture from April 2015 to June 2018. Demographic,
Henrique Yuji Watanabe Silva +1 more
doaj +2 more sources
Echinocandins in invasive candidiasis
Mycoses, 2013 SummaryWe summarise a recent meeting, sponsored by Pfizer Inc., where experts in Asia shared their clinical experience in managingIC. The echinocandins have demonstrated good activity against non‐albicansinfections and also azole‐resistant strains, both preclinically and in recent clinical trials.
Simon, J. +13 more
openaire +3 more sources
Invasive Candidiasis Associated with Adenovirus Pneumonia [PDF]
, 2021 Invasive Candida infections in immunocompetent children lead to high morbidity and mortality despite available treatment. Candida albicans and Candida parapsilosis are the most common pathogens; however, there are newly emerging pathogenic non-albicans ...
Madhusha Gonapaladeniya +2 more
core +1 more source
Fluconazole prophylaxis in preterm infants: a systematic review
Brazilian Journal of Infectious Diseases, 2017 Objective: This article aims to review the use of antifungal prophylaxis with intravenous fluconazole in premature newborns and the occurrence of Invasive Candidiasis.
Juliana Ferreira da Silva Rios +3 more
doaj +1 more source
Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy
International Journal of Pediatrics, 2011 Objective/Methods. To determine the outcomes of invasive neonatal candidiasis before institution of routine antifungal prophylaxis, we conducted a retrospective review of cases of invasive candidiasis in newborns in a referral-based neonatal intensive ...
Heather Cahan, Jaime G. Deville
doaj +1 more source
Vaccines in the treatment of invasive candidiasis [PDF]
Virulence, 2015 Candida albicans is the most common cause of hematogenously disseminated candidiasis, and this disease is particularly prevalent in immunocompromised patients. The mortality of invasive candidiasis remains 40% to 50% even with the proper treatment with current antifungal drugs.
Wang, Xiao-juan +5 more
openaire +2 more sources
Treatment and Prophylaxis of Invasive Candidiasis [PDF]
Seminars in Perinatology, 2012 Invasive candidiasis (IC) is a leading cause of morbidity and mortality in preterm infants. Even if successfully treated, IC can cause significant neurodevelopmental impairment. Preterm infants are at increased risk for hematogenous Candida meningoencephalitis owing to increased permeability of the blood-brain barrier, so antifungal treatment should ...
Nidhi, Tripathi +2 more
openaire +2 more sources